Puma Biotechnology Raises FY2026 Sales Guidance from $222.000M-$229.000M to $224.000M-$231.000M vs $222.000M Est
Puma Biotechnology (NASDAQ: PBYI ) raises FY2026 sales outlook from $222.000 million-$229.000 million to $224.000 million-$231.000 million vs $222.000 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.